Addyi was first approved with the FDA in August 2015 to treat hypoactive sexual drive condition (HSDD) in premenopausal Females. That is just another way of saying it boosts intercourse generate (also referred to as libido) in women that have not reached menopause. It had been the initial such drug http://bostanli.bozyakacilingir.net/